Issue Archive
|
About Us
|
Contact Us
|
Subscribe
|
Editorial Board
|
Author Guidelines
|
About Haymarket Media
Home
News
Web Exclusives
Daily Oncology News
In the News
New Drug Products
ASH 2011
ASCO 2011
ONS Annual Congress 2011
ASH 2010
CE
CE Articles
mycme.com
Departments
Advisor Forum
Ask a Pharmacist
Case Study
Communication Challenges
From CancerCare
In the News
Issues in Cancer Survivorship
Radiation and Your Patient
Reflections
Stat Consult
The Patient's Voice
The Total Patient
Issue Archive
Topics
Chemotherapy
Communication
End-of-Life Issues
Pain Management
Palliative Care
Radiology
Side-Effect Management
Survivorship
Women's Health
Cancer Types
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Chemotherapy Regimens
Clinical Trials
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
For Your Patient
Advocacy
CancerCare Fact Sheets
Cancer Support Groups
Financial Assistance
Finding Clinical Trials
Palliative Care and Hospice
Patient Information
The Total Nurse
General Medicine in Oncology
Slideshows
Supplements
Jobs
Tools & Links
RSS
|
Login
|
Register
ONA
> Advisor Forum
Advisor Forum
Oncology Nurse Advisor Forum - September/October 2011
October 18, 2011
The Advisor Forum panel answers nurses' questions about hair loss, mammography timing, and turnaround time for oral chemotherapy agents.
Oncology Nurse Advisor Forum - July/August 2011
August 01, 2011
Based on associations between HPV and head and neck cancer, what public health initiatives should be implemented? What is the significance of food-drug interactions with oral TKIs?
Oncology Nurse Advisor Forum - May/June 2011
June 01, 2011
The Forum answers questions on the effects of antidepressants on tamoxifen and smoking while on chemotherapy.
Oncology Nurse Advisor Forum - March/April 2011
April 01, 2011
The Advisor Forum panel answers nurses' questions about patient care, treatment regimens, and oncology nursing.
Oncology Nurse Advisor Forum - January/February 2011
February 01, 2011
The Forum answers questions about desquamation under the breasts, Medicare guidelines for Procrit and Aranesp, hydration during cyclophosphamide, and ionized calcium and calcium level differences.
Oncology Nurse Advisor Forum - November/December 2010
November 01, 2010
The forum answers questions about curcumin, MUGA scans, administering bortezomib, and more.
Oncology Nurse Advisor Forum - October 2010
September 27, 2010
The forum answers questions about the effects of pectin and administering chemotherapy with no blood return.
Oncology Nurse Advisor Forum - August/September 2010
August 01, 2010
The advisor forum answers questions about peripheral neuropathy, specialty pharmacies, fatigue following breast cancer treatment, and more.
Oncology Nurse Advisor Forum - July 2010
July 14, 2010
The advisor forum answers questions about addressing code status, low immunoglobulin levels, radioimmunotherapy, and more.
Oncology Nurse Advisor Forum - June 2010
June 14, 2010
The advisor forum answers questions about anemia, nurse navigators, chemotherapy-associated rashes, and more.
more »
ClinicalJobAdvisor
Loading...
More Jobs
Subscribe to the RSS for this page [
view all our RSS feeds here
]
Web Exclusives
Side effects of certain cancer drugs may be fatal
Delicia Honen Yard
February 22, 2012
Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
High-definition blood test may become comparable to biopsy
Delicia Honen Yard
February 21, 2012
An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy
Delicia Honen Yard
February 20, 2012
A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
more »